Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F W Verheugt

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|April 27, 2004
[Passive smoking and the risk of coronary heart disease]F W Verheugt
Nederlands Tijdschrift Voor Geneeskunde|July 18, 1992
[Secondary prevention of ischemic heart disease: a struggle on 2 fronts]F W Verheugt
Lancet (London, England)|May 17, 1997
In search of a superaspirin for the heartF W Verheugt
Nederlands Tijdschrift Voor Geneeskunde|March 14, 1987
[Intracoronary thrombosis as an acute expression of coronary heart disease]F W Verheugt
Nederlands Tijdschrift Voor Geneeskunde|March 11, 1989
[Antithrombotic agents]F W Verheugt
European Heart Journal|November 2, 1999
Hotline sessions of the 21st European Congress of CardiologyF W Verheugt
Thrombosis and Haemostasis|March 1, 2000
Anticoagulation after artificial valve replacement with or without atrial fibrillation: how much is really needed?F W Verheugt
European Heart Journal|December 5, 2000
Hotline sessions at the 22nd European Congress of CardiologyF W Verheugt
Nederlands Tijdschrift Voor Geneeskunde|September 27, 2001
[Misleading advertisement of Adalat Oros]F W Verheugt
Lancet (London, England)|June 27, 2001
GUSTO V: the bottom line of fibrinolytic reperfusion therapyF W Verheugt
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Nederlands Tijdschrift Voor Geneeskunde|April 27, 2004
[Passive smoking and the risk of coronary heart disease]F W Verheugt
Nederlands Tijdschrift Voor Geneeskunde|July 18, 1992
[Secondary prevention of ischemic heart disease: a struggle on 2 fronts]F W Verheugt
Lancet (London, England)|May 17, 1997
In search of a superaspirin for the heartF W Verheugt
Nederlands Tijdschrift Voor Geneeskunde|March 14, 1987
[Intracoronary thrombosis as an acute expression of coronary heart disease]F W Verheugt
Nederlands Tijdschrift Voor Geneeskunde|March 11, 1989
[Antithrombotic agents]F W Verheugt
European Heart Journal|November 2, 1999
Hotline sessions of the 21st European Congress of CardiologyF W Verheugt
Thrombosis and Haemostasis|March 1, 2000
Anticoagulation after artificial valve replacement with or without atrial fibrillation: how much is really needed?F W Verheugt
European Heart Journal|December 5, 2000
Hotline sessions at the 22nd European Congress of CardiologyF W Verheugt
Nederlands Tijdschrift Voor Geneeskunde|September 27, 2001
[Misleading advertisement of Adalat Oros]F W Verheugt
Lancet (London, England)|June 27, 2001
GUSTO V: the bottom line of fibrinolytic reperfusion therapyF W Verheugt
Pageof 16